Alpha-synuclein toxicity in the early secretory pathway: How it drives neurodegeneration in parkinsons disease

Frontiers in Neuroscience

Volumn 9, Issue NOV, 2015, Pages

  Wang, Ting ^a,b   Hay, Jesse C ^a  

^a UNIVERSITY OF MONTANA   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Alpha synuclein; ER stress response; ER to golgi transport; Golgi; LRRK2; Neurodegenerative diseases; Parkinson disease; Vesicle trafficking

Indexed keywords

ALPHA SYNUCLEIN; PROTEASOME; UBIQUITIN;

CELL TRANSPORT; ENDOLYSOSOME; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM ASSOCIATED DEGRADATION; ENDOPLASMIC RETICULUM STRESS; GOLGI COMPLEX; HOMEOSTASIS; HUMAN; LYSOSOME; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PROTEIN ANALYSIS; PROTEIN CLEARANCE; PROTEIN FUNCTION; SECRETORY CELL; SHORT SURVEY; SYNAPSE;

EID: 84949567628     PISSN: 16624548     EISSN: 1662453X     Source Type: Journal    
DOI: 10.3389/fnins.2015.00433     Document Type: Short Survey

References (96)

1. Abeliovich, A., Schmitz, Y., Fariñas, I., Choi-Lundberg, D., Ho, W. H., Castillo, P. E., et al. (2000). Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 25, 239-252. doi: 10.1016/S0896-6273(00)80886-7.
2. Alvarez-Erviti, L., Seow, Y., Schapira, A. H., Gardiner, C., Sargent, I. L., Wood, M. J., et al. (2011). Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission. Neurobiol. Dis. 42, 360-367. doi: 10.1016/j.nbd.2011.01.029.
3. Atkin, J. D., Farg, M. A., Soo, K. Y., Walker, A. K., Halloran, M., Turner, B. J., et al. (2014). Mutant SOD1 inhibits ER-Golgi transport in amyotrophic lateral sclerosis. J. Neurochem. 129, 190-204. doi: 10.1111/jnc.12493.
4. Bartels, T., Ahlstrom, L. S., Leftin, A., Kamp, F., Haass, C., Brown, M. F., et al. (2010). The N-terminus of the intrinsically disordered protein a-synuclein triggers membrane binding and helix folding. Biophys. J. 99, 2116-2124. doi: 10.1016/j.bpj.2010.06.035.
5. Bartels, T., Choi, J. G., and Selkoe, D. J. (2011). a-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation. Nature 477, 107-110. doi: 10.1038/nature10324.
6. Beilina, A., Rudenko, I. N., Kaganovich, A., Civiero, L., Chau, H., Kalia, S. K., et al. (2014). Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease. Proc. Natl. Acad. Sci. U.S.A. 111, 2626-2631. doi: 10.1073/pnas.1318306111.
7. Belal, C., Ameli, N. J., El Kommos, A., Bezalel, S., Al'Khafaji, A. M., Mughal, M. R., et al. (2012). The homocysteine-inducible endoplasmic reticulum (ER) stress protein Herp counteracts mutant a-synuclein-induced ER stress via the homeostatic regulation of ER-resident calcium release channel proteins. Hum. Mol. Genet. 21, 963-977. doi: 10.1093/hmg/ddr502.
8. Bendor, J. T., Logan, T. P., and Edwards, R. H. (2013). The function of alpha-synuclein. Neuron 79, 1044-1066. doi: 10.1016/j.neuron.2013.09.004.
9. Ben Gedalya, T., Loeb, V., Israeli, E., Altschuler, Y., Selkoe, D. J., and Sharon, R. (2009). Alpha-synuclein and polyunsaturated fatty acids promote clathrin-mediated endocytosis and synaptic vesicle recycling. Traffic 10, 218-234. doi: 10.1111/j.1600-0854.2008.00853.x.
10. Bexiga, M. G., and Simpson, J. C. (2013). Human diseases associated with form and function of the Golgi complex. Int. J. Mol. Sci. 14, 18670-18681. doi: 10.3390/ijms140918670.
11. Breda, C., Nugent, M. L., Estranero, J. G., Kyriacou, C. P., Outeiro, T. F., Steinert, J. R., et al. (2015). Rab11 modulates alpha-synuclein-mediated defects in synaptic transmission and behaviour. Hum. Mol. Genet. 24, 1077-1091. doi: 10.1093/hmg/ddu521.
12. Burré, J., Sharma, M., and Südhof, T. C. (2014). alpha-Synuclein assembles into higher-order multimers upon membrane binding to promote SNARE complex formation. Proc. Natl. Acad. Sci. U.S.A. 111, E4274-E4283. doi: 10.1073/pnas.1416598111.
13. Burré, J., Sharma, M., Tsetsenis, T., Buchman, V., Etherton, M. R., and Sudhof, T. C. (2010). Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro. Science 329, 1663-1667. doi: 10.1126/science.1195227.
14. Cabin, D. E., Shimazu, K., Murphy, D., Cole, N. B., Gottschalk, W., McIlwain, K. L., et al. (2002). Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein. J. Neurosci. 22, 8797-8807.
15. Chandra, S., Gallardo, G., Fernández-Chacón, R., Schlüter, O. M., and Südhof, T. C. (2005). Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. Cell 123, 383-396. doi: 10.1016/j.cell.2005.09.028.
16. Chen, R. H., Wislet-Gendebien, S., Samuel, F., Visanji, N. P., Zhang, G., Marsilio, D., et al. (2013). alpha-Synuclein membrane association is regulated by the Rab3a recycling machinery and presynaptic activity. J. Biol. Chem. 288, 7438-7449. doi: 10.1074/jbc. M112.439497.
17. Cheng, F., Li, X., Li, Y., Wang, C., Wang, T., Liu, G., et al. (2011). alpha-Synuclein promotes clathrin-mediated NMDA receptor endocytosis and attenuates NMDA-induced dopaminergic cell death. J. Neurochem. 119, 815-825. doi: 10.1111/j.1471-4159.2011.07460.x.
18. Chigurupati, S., Wei, Z., Belal, C., Vandermey, M., Kyriazis, G. A., Arumugam, T. V., et al. (2009). The homocysteine-inducible endoplasmic reticulum stress protein counteracts calcium store depletion and induction of CCAAT enhancer-binding protein homologous protein in a neurotoxin model of Parkinson disease. J. Biol. Chem. 284, 18323-18333. doi: 10.1074/jbc. M109.020891.
19. Cho, H. J., Yu, J., Xie, C., Rudrabhatla, P., Chen, X., Wu, J., et al. (2014). Leucine-rich repeat kinase 2 regulates Sec16A at ER exit sites to allow ER-Golgi export. EMBO J. 33, 2314-2331. doi: 10.15252/embj.201487807.
20. Choi, B. K., Choi, M. G., Kim, J. Y., Yang, Y., Lai, Y., Kweon, D. H., et al. (2013). Large alpha-synuclein oligomers inhibit neuronal SNARE-mediated vesicle docking. Proc. Natl. Acad. Sci. U.S.A. 110, 4087-4092. doi: 10.1073/pnas.1218424110.
21. Choi, B. K., Kim, J. Y., Cha, M. Y., Mook-Jung, I., Shin, Y. K., and Lee, N. K. (2015). beta-Amyloid and alpha-synuclein cooperate to block SNARE-dependent vesicle fusion. Biochemistry 54, 1831-1840. doi: 10.1021/acs.biochem.5b00087.
22. Chua, C. E., and Tang, B. L. (2013). Linking membrane dynamics and trafficking to autophagy and the unfolded protein response. J. Cell Physiol. 228, 1638-1640. doi: 10.1002/jcp.24341.
23. Colla, E., Coune, P., Liu, Y., Pletnikova, O., Troncoso, J. C., Iwatsubo, T., et al. (2012a). Endoplasmic reticulum stress is important for the manifestations of alpha-synucleinopathy in vivo. J. Neurosci. 32, 3306-3320. doi: 10.1523/JNEUROSCI.5367-11.2012.
24. Colla, E., Jensen, P. H., Pletnikova, O., Troncoso, J. C., Glabe, C., and Lee, M. K. (2012b). Accumulation of toxic a-synuclein oligomer within endoplasmic reticulum occurs in a-synucleinopathy in vivo. J. Neurosci. 32, 3301-3305. doi: 10.1523/JNEUROSCI.5368-11.2012.
25. Cooper, A. A., Gitler, A. D., Cashikar, A., Haynes, C. M., Hill, K. J., Bhullar, B., et al. (2006). Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. Science 313, 324-328. doi: 10.1126/science.1129462.
26. Coune, P. G., Bensadoun, J. C., Aebischer, P., and Schneider, B. L. (2011). Rab1A over-expression prevents Golgi apparatus fragmentation and partially corrects motor deficits in an alpha-synuclein based rat model of Parkinson's disease. J. Parkinsons Dis. 1, 373-387. doi: 10.3233/JPD-2011-11058.
27. Credle, J. J., Forcelli, P. A., Delannoy, M., Oaks, A. W., Permaul, E., Berry, D. L., et al. (2015). alpha-Synuclein-mediated inhibition of ATF6 processing into COPII vesicles disrupts UPR signaling in Parkinson's disease. Neurobiol. Dis. 76, 112-125. doi: 10.1016/j.nbd.2015.02.005.
28. Dalfó, E., Gomez-Isla, T., Rosa, J. L., Nieto Bodelón, M., Cuadrado Tejedor, M., Barrachina, M., et al. (2004). Abnormal alpha-synuclein interactions with Rab proteins in alpha-synuclein A30P transgenic mice. J. Neuropathol. Exp. Neurol. 63, 302-313.
29. Deleersnijder, A., Gerard, M., Debyser, Z., and Baekelandt, V. (2013). The remarkable conformational plasticity of alpha-synuclein: blessing or curse? Trends Mol. Med. 19, 368-377. doi: 10.1016/j.molmed.2013.04.002.
30. DeWitt, D. C., and Rhoades, E. (2013). alpha-Synuclein can inhibit SNARE-mediated vesicle fusion through direct interactions with lipid bilayers. Biochemistry 52, 2385-2387. doi: 10.1021/bi4002369.
31. Diao, J., Burré, J., Vivona, S., Cipriano, D. J., Sharma, M., Kyoung, M., et al. (2013). Native alpha-synuclein induces clustering of synaptic-vesicle mimics via binding to phospholipids and synaptobrevin-2/VAMP2. Elife 2:e00592. doi: 10.7554/eLife.00592.
32. Exner, N., Lutz, A. K., Haass, C., and Winklhofer, K. F. (2012). Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences. EMBO J. 31, 3038-3062. doi: 10.1038/emboj.2012.170.
33. Fan, J., Hu, Z., Zeng, L., Lu, W., Tang, X., Zhang, J., et al. (2008). Golgi apparatus and neurodegenerative diseases. Int. J. Dev. Neurosci. 26, 523-534. doi: 10.1016/j.ijdevneu.2008.05.006.
34. Flower, T. R., Clark-Dixon, C., Metoyer, C., Yang, H., Shi, R., Zhang, Z., et al. (2007). YGR198w (YPP1) targets A30P alpha-synuclein to the vacuole for degradation. J. Cell Biol. 177, 1091-1104. doi: 10.1083/jcb.200610071.
35. Fortin, D. L., Troyer, M. D., Nakamura, K., Kubo, S., Anthony, M. D., and Edwards, R. H. (2004). Lipid rafts mediate the synaptic localization of alpha-synuclein. J. Neurosci. 24, 6715-6723. doi: 10.1523/JNEUROSCI.1594-04.2004.
36. Fouillet, A., Levet, C., Virgone, A., Robin, M., Dourlen, P., Rieusset, J., et al. (2012). ER stress inhibits neuronal death by promoting autophagy. Autophagy 8, 915-926. doi: 10.4161/auto.19716.
37. Gitler, A. D., Bevis, B. J., Shorter, J., Strathearn, K. E., Hamamichi, S., Su, L. J., et al. (2008). The Parkinson's disease protein alpha-synuclein disrupts cellular Rab homeostasis. Proc. Natl. Acad. Sci. U.S.A. 105, 145-150. doi: 10.1073/pnas.0710685105.
38. Gonatas, N. K., Stieber, A., and Gonatas, J. O. (2006). Fragmentation of the Golgi apparatus in neurodegenerative diseases and cell death. J. Neurol. Sci. 246, 21-30. doi: 10.1016/j.jns.2006.01.019.
39. Gosavi, N., Lee, H. J., Lee, J. S., Patel, S., and Lee, S. J. (2002). Golgi fragmentation occurs in the cells with prefibrillar alpha-synuclein aggregates and precedes the formation of fibrillar inclusion. J. Biol. Chem. 277, 48984-48992. doi: 10.1074/jbc. M208194200.
40. Greten-Harrison, B., Polydoro, M., Morimoto-Tomita, M., Diao, L., Williams, A. M., Nie, E. H., et al. (2010). alphabetagamma-Synuclein triple knockout mice reveal age-dependent neuronal dysfunction. Proc. Natl. Acad. Sci. U.S.A. 107, 19573-19578. doi: 10.1073/pnas.1005005107.
41. Guerreiro, P. S., Huang, Y., Gysbers, A., Cheng, D., Gai, W. P., Outeiro, T. F., et al. (2013). LRRK2 interactions with alpha-synuclein in Parkinson's disease brains and in cell models. J. Mol. Med. (Berl). 91, 513-522. doi: 10.1007/s00109-012-0984-y.
42. He, C., and Klionsky, D. J. (2009). Regulation mechanisms and signaling pathways of autophagy. Ann. Rev. Genet. 43, 67-93. doi: 10.1146/annurev-genet-102808-114910.
43. Kahle, P. J., Neumann, M., Ozmen, L., Muller, V., Jacobsen, H., Schindzielorz, A., et al. (2000). Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha-synuclein in human and transgenic mouse brain. J. Neurosci. 20, 6365-6373.
44. Khalaf, O., Fauvet, B., Oueslati, A., Dikiy, I., Mahul-Mellier, A.-L., Ruggeri, F. S., et al. (2014). The H50Q mutation enhances a-synuclein aggregation, secretion, and toxicity. J. Biol. Chem. 289, 21856-21876. doi: 10.1074/jbc. M114.553297.
45. Kingsbury, A. E., Bandopadhyay, R., Silveira-Moriyama, L., Ayling, H., Kallis, C., Sterlacci, W., et al. (2010). Brain stem pathology in Parkinson's disease: an evaluation of the Braak staging model. Mov. Disord. 25, 2508-2515. doi: 10.1002/mds.23305.
46. Kitao, Y., Imai, Y., Ozawa, K., Kataoka, A., Ikeda, T., Soda, M., et al. (2007). Pael receptor induces death of dopaminergic neurons in the substantia nigra via endoplasmic reticulum stress and dopamine toxicity, which is enhanced under condition of parkin inactivation. Hum. Mol. Genet. 16, 50-60. doi: 10.1093/hmg/ddl439.
47. Kroemer, G., Mariño, G., and Levine, B. (2010). Autophagy and the integrated stress response. Mol. Cell. 40, 280-293. doi: 10.1016/j.molcel.2010.09.023.
48. Kumari, U., and Tan, E. K. (2009). LRRK2 in Parkinson's disease: genetic and clinical studies from patients. FEBS J. 276, 6455-6463. doi: 10.1111/j.1742-4658.2009.07344.x.
49. Lai, Y., Kim, S., Varkey, J., Lou, X., Song, J. K., Diao, J., et al. (2014). Nonaggregated alpha-synuclein influences SNARE-dependent vesicle docking via membrane binding. Biochemistry 53, 3889-3896. doi: 10.1021/bi5002536.
50. Lee, H. J., Cho, E. D., Lee, K. W., Kim, J. H., Cho, S. G., and Lee, S. J. (2013). Autophagic failure promotes the exocytosis and intercellular transfer of alpha-synuclein. Exp. Mol. Med. 45, e22. doi: 10.1038/emm.2013.45.
51. Lee, H. J., Kang, S. J., Lee, K., and Im, H. (2011). Human alpha-synuclein modulates vesicle trafficking through its interaction with prenylated Rab acceptor protein 1. Biochem. Biophys. Res. Commun. 412, 526-531. doi: 10.1016/j.bbrc.2011.07.028.
52. Lee, H. J., Khoshaghideh, F., Lee, S., and Lee, S. J. (2006). Impairment of microtubule-dependent trafficking by overexpression of alpha-synuclein. Eur. J. Neurosci. 24, 3153-3162. doi: 10.1111/j.1460-9568.2006.05210.x.
53. Lee, H. J., Suk, J. E., Bae, E. J., Lee, J. H., Paik, S. R., and Lee, S. J. (2008). Assembly-dependent endocytosis and clearance of extracellular alpha-synuclein. Int. J. Biochem. Cell Biol. 40, 1835-1849. doi: 10.1016/j.biocel.2008.01.017.
54. Lin, X., Parisiadou, L., Gu, X.-L., Wang, L., Shim, H., Sun, L., et al. (2009). Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson's-disease-related mutant alpha-synuclein. Neuron 64, 807-827. doi: 10.1016/j.neuron.2009.11.006.
55. Lionaki, E., Markaki, M., Palikaras, K., and Tavernarakis, N. (2015). Mitochondria, autophagy and age-associated neurodegenerative diseases: new insights into a complex interplay. Biochim. Biophys. Acta 1847, 1412-1423. doi: 10.1016/j.bbabio.2015.04.010.
56. Liu, J., Zhang, J. P., Shi, M., Quinn, T., Bradner, J., Beyer, R., et al. (2009). Rab11a and HSP90 regulate recycling of extracellular alpha-synuclein. J. Neurosci. 29, 1480-1485. doi: 10.1523/JNEUROSCI.6202-08.2009.
57. Maroteaux, L., Campanelli, J. T., and Scheller, R. H. (1988). Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J. Neurosci. 8, 2804-2815.
58. Mercado, G., Valdés, P., and Hetz, C. (2013). An ERcentric view of Parkinson's disease. Trends Mol. Med. 19, 165-175. doi: 10.1016/j.molmed.2012.12.005.
59. Mignogna, M. L., Giannandrea, M., Gurgone, A., Fanelli, F., Raimondi, F., Mapelli, L., et al. (2015). The intellectual disability protein RAB39B selectively regulates GluA2 trafficking to determine synaptic AMPAR composition. Nat. Commun. 6, 6504. doi: 10.1038/ncomms7504.
60. Murphy, D. D., Rueter, S. M., Trojanowski, J. Q., and Lee, V. M. (2000). Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons. J. Neurosci. 20, 3214-3220.
61. Nakagomi, S., Barsoum, M. J., Bossy-Wetzel, E., Sütterlin, C., Malhotra, V., and Lipton, S. A. (2008). A Golgi fragmentation pathway in neurodegeneration. Neurobiol. Dis. 29, 221-231. doi: 10.1016/j.nbd.2007.08.015.
62. Nemani, V. M., Lu, W., Berge, V., Nakamura, K., Onoa, B., Lee, M. K., et al. (2010). Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis. Neuron 65, 66-79. doi: 10.1016/j.neuron.2009.12.023.
63. Ninkina, N., Peters, O. M., Connor-Robson, N., Lytkina, O., Sharfeddin, E., and Buchman, V. L. (2012). Contrasting effects of alpha-synuclein and gamma-synuclein on the phenotype of cysteine string protein alpha (CSPalpha) null mutant mice suggest distinct function of these proteins in neuronal synapses. J. Biol. Chem. 287, 44471-44477. doi: 10.1074/jbc. M112.422402.
64. Oaks, A. W., Marsh-Armstrong, N., Jones, J. M., Credle, J. J., and Sidhu, A. (2013). Synucleins antagonize endoplasmic reticulum function to modulate dopamine transporter trafficking. PLoS ONE 8:e70872. doi: 10.1371/journal.pone.0070872.
65. Omura, T., Kaneko, M., Okuma, Y., Matsubara, K., and Nomura, Y. (2013). Endoplasmic reticulum stress and Parkinson's disease: the role of HRD1 in averting apoptosis in neurodegenerative disease. Oxid. Med. Cell Longev. 2013:239854. doi: 10.1155/2013/239854.
66. Oueslati, A., Fournier, M., and Lashuel, H. A. (2010). Role of post-translational modifications in modulating the structure, function and toxicity of alpha-synuclein: implications for Parkinson's disease pathogenesis and therapies. Prog. Brain Res. 183, 115-145. doi: 10.1016/S0079-6123(10)83007-9.
67. Paleologou, K. E., Oueslati, A., Shakked, G., Rospigliosi, C. C., Kim, H. Y., Lamberto, G. R., et al. (2010). Phosphorylation at S87 is enhanced in synucleinopathies, inhibits alpha-synuclein oligomerization, and influences synuclein-membrane interactions. J. Neurosci. 30, 3184-3198. doi: 10.1523/JNEUROSCI.5922-09.2010.
68. Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., et al. (1997). Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276, 2045-2047. doi: 10.1126/science.276.5321.2045.
69. Pranke, I. M., Morello, V., Bigay, J., Gibson, K., Verbavatz, J.-M., Antonny, B., et al. (2011). α-Synuclein and ALPS motifs are membrane curvature sensors whose contrasting chemistry mediates selective vesicle binding. J. Cell Biol. 194, 89-103. doi: 10.1083/jcb.201011118.
70. Qing, H., Wong, W., McGeer, E. G., and McGeer, P. L. (2009). Lrrk2 phosphorylates alpha synuclein at serine 129: Parkinson disease implications. Biochem. Biophys. Res. Commun. 387, 149-152. doi: 10.1016/j.bbrc.2009.06.142.
71. Reiling, J. H., Olive, A. J., Sanyal, S., Carette, J. E., Brummelkamp, T. R., Ploegh, H. L., et al. (2013). A CREB3-ARF4 signalling pathway mediates the response to Golgi stress and susceptibility to pathogens. Nat. Cell Biol. 15, 1473-1485. doi: 10.1038/ncb2865.
72. Rendón, W. O., Martinez-Alonso, E., Tomas, M., Martínez-Martínez, N., and Martínez-Menárguez, J. A. (2013). Golgi fragmentation is Rab and SNARE dependent in cellular models of Parkinson's disease. Histochem. Cell Biol. 139, 671-684. doi: 10.1007/s00418-012-1059-4.
73. Salganik, M., Sergeyev, V. G., Shinde, V., Meyers, C. A., Gorbatyuk, M. S., Lin, J. H., et al. (2015). The loss of glucose-regulated protein 78 (GRP78) during normal aging or from siRNA knockdown augments human alpha-synuclein (alpha-syn) toxicity to rat nigral neurons. Neurobiol. Aging 36, 2213-2223. doi: 10.1016/j.neurobiolaging.2015.02.018.
74. Schulze, A., Standera, S., Buerger, E., Kikkert, M., van Voorden, S., Wiertz, E., et al. (2005). The ubiquitin-domain protein HERP forms a complex with components of the endoplasmic reticulum associated degradation pathway. J. Mol. Biol. 354, 1021-1027. doi: 10.1016/j.jmb.2005.10.020.
75. Slodzinski, H., Moran, L. B., Michael, G. J., Wang, B., Novoselov, S., Cheetham, M. E., et al. (2009). Homocysteine-induced endoplasmic reticulum protein (herp) is up-regulated in parkinsonian substantia nigra and present in the core of Lewy bodies. Clin. Neuropathol. 28, 333-343. doi: 10.2379/NPX08162.
76. Smith, W. W., Jiang, H., Pei, Z., Tanaka, Y., Morita, H., Sawa, A., et al. (2005). Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity. Hum. Mol. Genet. 14, 3801-3811. doi: 10.1093/hmg/ddi396.
77. Snead, D., and Eliezer, D. (2014). Alpha-synuclein function and dysfunction on cellular membranes. Exp. Neurobiol. 23, 292-313. doi: 10.5607/en.2014.23.4.292.
78. Soper, J. H., Kehm, V., Burd, C. G., Bankaitis, V. A., and Lee, V. M. (2011). Aggregation of alpha-synuclein in S. cerevisiae is associated with defects in endosomal trafficking and phospholipid biosynthesis. J. Mol. Neurosci. 43, 391-405. doi: 10.1007/s12031-010-9455-5.
79. Soper, J. H., Roy, S., Stieber, A., Lee, E., Wilson, R. B., Trojanowski, J. Q., et al. (2008). Alpha-synuclein-induced aggregation of cytoplasmic vesicles in Saccharomyces cerevisiae. Mol. Biol. Cell. 19, 1093-1103. doi: 10.1091/mbc. E07-08-0827.
80. Spooner, R. A., and Lord, J. M. (2012). How ricin and Shiga toxin reach the cytosol of target cells: retrotranslocation from the endoplasmic reticulum. Curr. Top. Microbiol. Immunol. 357, 19-40. doi: 10.1007/82_2011_154.
81. Su, L. J., Auluck, P. K., Outeiro, T. F., Yeger-Lotem, E., Kritzer, J. A., Tardiff, D. F., et al. (2010). Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson's disease models. Dis. Model. Mech. 3, 194-208. doi: 10.1242/dmm.004267.
82. Sun, K.-H., de Pablo, Y., Vincent, F., Johnson, E. O., Chavers, A. K., and Shah, K. (2008). Novel genetic tools reveal Cdk5's major role in Golgi fragmentation in Alzheimer's disease. Mol. Biol. Cell. 19, 3052-3069. doi: 10.1091/mbc. E07-11-1106.
83. Tanik, S. A., Schultheiss, C. E., Volpicelli-Daley, L. A., Brunden, K. R., and Lee, V. M. (2013). Lewy body-like alpha-synuclein aggregates resist degradation and impair macroautophagy. J. Biol. Chem. 288, 15194-15210. doi: 10.1074/jbc. M113.457408.
84. Tardiff, D. F., Jui, N. T., Khurana, V., Tambe, M. A., Thompson, M. L., Chung, C. Y., et al. (2013). Yeast reveal a "druggable" Rsp5/Nedd4 network that ameliorates a-synuclein toxicity in neurons. Science 342, 979-983. doi: 10.1126/science.1245321.
85. Thayanidhi, N., Helm, J. R., Nycz, D. C., Bentley, M., Liang, Y., and Hay, J. C. (2010). Alpha-synuclein delays endoplasmic reticulum (ER)-to-Golgi transport in mammalian cells by antagonizing ER/Golgi SNAREs. Mol. Biol. Cell. 21, 1850-1863. doi: 10.1091/mbc. E09-09-0801.
86. Thayer, D. A., Jan, Y. N., and Jan, L. Y. (2013). Increased neuronal activity fragments the Golgi complex. Proc. Natl. Acad. Sci. U.S.A. 110, 1482-1487. doi: 10.1073/pnas.1220978110.
87. Tsai, Y. C., Fishman, P. S., Thakor, N. V., and Oyler, G. A. (2003). Parkin facilitates the elimination of expanded polyglutamine proteins and leads to preservation of proteasome function. J. Biol. Chem. 278, 22044-22055. doi: 10.1074/jbc. M212235200.
88. Valdés, P., Mercado, G., Vidal, R. L., Molina, C., Parsons, G., Court, F. A., et al. (2014). Control of dopaminergic neuron survival by the unfolded protein response transcription factor XBP1. Proc. Natl. Acad. Sci. U.S.A. 111, 6804-6809. doi: 10.1073/pnas.1321845111.
89. van Dijk, K. D., Persichetti, E., Chiasserini, D., Eusebi, P., Beccari, T., Calabresi, P., et al. (2013). Changes in endolysosomal enzyme activities in cerebrospinal fluid of patients with Parkinson's disease. Mov. Disord. 28, 747-754. doi: 10.1002/mds.25495.
90. Vargas, K. J., Makani, S., Davis, T., Westphal, C. H., Castillo, P. E., and Chandra, S. S. (2014). Synucleins regulate the kinetics of synaptic vesicle endocytosis. J. Neurosci. 34, 9364-9376. doi: 10.1523/JNEUROSCI.4787-13.2014.
91. Volpicelli-Daley, L. A., Gamble, K. L., Schultheiss, C. E., Riddle, D. M., West, A. B., and Lee, V. M. (2014). Formation of alpha-synuclein Lewy neurite-like aggregates in axons impedes the transport of distinct endosomes. Mol. Biol. Cell. 25, 4010-4023. doi: 10.1091/mbc. E14-02-0741.
92. Watson, P., Townley, A. K., Koka, P., Palmer, K. J., and Stephens, D. J. (2006). Sec16 defines endoplasmic reticulum exit sites and is required for secretory cargo export in mammalian cells. Traffic 7, 1678-1687. doi: 10.1111/j.1600-0854.2006.00493.x.
93. Wilson, G. R., Sim, J. C. H., McLean, C., Giannandrea, M., Galea, C. A., Riseley, J. R., et al. (2014). Mutations in RAB39B cause X-linked intellectual disability and early-onset Parkinson disease with a-synuclein pathology. Am. J. Hum. Genet. 95, 729-735. doi: 10.1016/j.ajhg.2014.10.015.
94. Winslow, A. R., Chen, C. W., Corrochano, S., Acevedo-Arozena, A., Gordon, D. E., Peden, A. A., et al. (2010). alpha-Synuclein impairs macroautophagy: implications for Parkinson's disease. J. Cell Biol. 190, 1023-1037. doi: 10.1083/jcb.201003122.
95. Yin, G., Lopes da Fonseca, T., Eisbach, S. E., Anduaga, A. M., Breda, C., Orcellet, M. L., et al. (2014). alpha-Synuclein interacts with the switch region of Rab8a in a Ser129 phosphorylation-dependent manner. Neurobiol. Dis. 70, 149-161. doi: 10.1016/j.nbd.2014.06.018.
96. Zarranz, J. J., Alegre, J., Gómez-Esteban, J. C., Lezcano, E., Ros, R., Ampuero, I., et al. (2004). The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann. Neurol. 55, 164-173. doi: 10.1002/ana.10795.